Regulatory & Legal

A new report projects massive growth in cardiovascular devices, driven by AI and minimally invasive tech. But can the healthcare system afford this progress?

With decades of military and crisis experience, Dow Knight is tasked with guiding disaster firm AshBritt into a new era of climate-driven challenges.

Following a landmark year of profitability, Carvana aims to make its stock more accessible to employees and investors with its first-ever stock split.

WeShop's new UK campaign offers shoppers a piece of the company, but financial warnings and user complaints raise questions about this retail revolution.

The parent of Meineke and Maaco admits to years of accounting errors, triggering a 40% stock collapse and a class action lawsuit from angry investors.

Groundbreaking Hong Kong research uncovers why the common ‘Asian Flush’ gene dramatically worsens heart attack outcomes, paving the way for new treatments.

As employers grapple with soaring obesity drug costs, a new partnership aims to offer predictable pricing and comprehensive care. Here's how it works.

With a $35 million boost from RA Capital, Equillium extends its cash runway to 2029, fueling the clinical development of its promising oral UC therapy, EQ504.

A new iPSC-derived cell therapy from Unixell Biotech has gained FDA approval for clinical trials, offering a regenerative approach for millions with epilepsy.

With domestic production falling and global supplies at risk, experts warn a helium shortage could cripple key U.S. industries from defense to semiconductors.

The German biotech firm secured its Nasdaq listing, but a near-total investor redemption leaves its cancer-drug pipeline with less than $1M in trust funds.

A landmark study reveals an accelerated brain stimulation protocol can treat major depression in six days, offering rapid relief and dismantling barriers to care.

A new tech-heavy vape launches in Africa, targeting youth with social apps and custom features, just as regulators and health officials declare war on vaping.

With a key regulatory approval, fintech firm QuantPower brings institutional-grade automated trading to everyday investors, signaling a shift in India's market.

An Australian firm's new modular smelter aims to unlock stranded iron ore value, promising lower-cost, clean steel and a manufacturing revival.

ROHM's new SiC modules are now on DigiKey, democratizing access to next-gen power tech for EVs and industry, challenging market leaders.

A manufacturing flaw in some Omnipod 5 insulin pods has caused serious health issues, prompting a company response and raising questions about device safety.

A coalition of 20 organizations has petitioned the state to ban lead ammunition, citing overwhelming evidence of harm to eagles, wildlife, and humans.

BNP Paribas more than doubles its scholarship program, awarding $200,000 to ten local high school tennis players and fueling their college dreams.

Ontario's watchdog launches a co-designed plan to tackle systemic racism and improve public service fairness for Indigenous communities across the province.